This trial will test the effectiveness of the Minds and Mentors Program (MiMP) in treating individuals with opioid use disorder. The study will compare the MiMP to Twelve Step Facilitation, and will measure outcomes such as adherence to medication, rates of relapse and cravings, and self-reported anxiety, stress, and depression. Additionally, the trial will examine whether pre-intervention cortisol reactivity is predictive of relapse outcomes, and/ or whether reductions in cortisol reactivity over the course of intervention mediate relapse outcomes.
1 Primary · 6 Secondary · Reporting Duration: 9 months
240 Total Participants · 2 Treatment Groups
Primary Treatment: Minds and Mentors · No Placebo Group · N/A
Age 18+ · All Participants · 9 Total Inclusion CriteriaMark “Yes” if the following statements are true for you: